Trailing-twelve-month (TTM) revenue is $613.81 Million with a year-over-year growth of +4.85%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-09-30 | $159,192,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-12-04 |
| Q1 FY2026Period ended 2025-12-31 | $148,642,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-05 |
| Q2 FY2026Period ended 2026-03-31 | $144,795,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q3 FY2026Period ended 2026-06-30 | $161,178,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $613,807,000 |
Current P/S: $2,114,276,919 market capitalization ÷ $613,807,000 TTM revenue = 3.44x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T13:40:16.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q3 FY2026 (2026-06-30): $161.18M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:41:02.873Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-09-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-09-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-09-30 · USD | FY20212021-09-30 · USD | FY20222022-09-30 · USD | FY20232023-09-30 · USD | FY20242024-09-30 · USD | FY20252025-09-30 · USD |
|---|---|---|---|---|---|---|
| Product | $574M | N/A | $181M | $277M | $243M | $173M |
| Products | N/A | $181M | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-09-30 · USD | FY20212021-09-30 · USD | FY20222022-09-30 · USD | FY20232023-09-30 · USD | FY20242024-09-30 · USD | FY20252025-09-30 · USD |
|---|---|---|---|---|---|---|
| Africa | N/A | N/A | N/A | $65M | $62M | N/A |
| Asia Pacific | N/A | N/A |
$613.81M
$613.81 Million
+4.85%
vs. $585.41M a year ago (TTM)
+4.82%
5 Year compound annual growth rate
1 Year
+4.85%
3 Year
(0.88%)
5 Year
+4.82%
10 Year
+1.13%
15 Year
(1.23%)
20 Year
+0.23%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $593.82M | +$20.37M | +3.55% |
| 2024 | $573.45M | ($91.62M) | (13.78%) |
| 2023 | $665.07M | +$109.57M | +19.73% |
| 2022 | $555.50M | +$41.80M | +8.14% |
| 2021 | $513.70M | +$125.17M | +32.21% |
| 2020 |
TTM Growth
+4.85%
3-Year CAGR
(0.88%)
5-Year CAGR
+4.82%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T13:41:02.873Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| Service | $323M | N/A | $375M | $388M | $413M | $421M |
|---|
| Services | N/A | $333M | N/A | N/A | N/A | N/A |
|---|
| N/A |
| $40M |
| $23M |
| Asia Pacific, Other than China | $417M | $81M | $29M | $52M | N/A | N/A |
|---|
| CHINA | N/A | N/A | $48M | $52M | $58M | $58M |
|---|
| Europe | $140M | $109M | $105M | $110M | $103M | $107M |
|---|
| North America | $340M | $324M | $374M | $359M | $366M | N/A |
|---|
| UNITED KINGDOM | N/A | N/A | N/A | $27M | $27M | $35M |
|---|
| $388.54M |
| ($392.31M) |
| (50.24%) |
| 2019 | $780.85M | +$149.29M | +23.64% |
| 2018 | $631.56M | +$104.06M | +19.73% |
| 2017 | $527.50M | ($32.82M) | (5.86%) |
| 2016 | $560.32M | +$7.62M | +1.38% |
